Mergers & Acquisitions | Tuesday, February 07
Positron, through its wholly owned subsidiary, Manhattan Isotope Technology (MIT), has executed a memorandum of understanding with the Institute of Nuclear Research (INR) of Troitsk, Russia. MIT and INR will collaborate on strontium-82 production beginning with a pharmaceutical ingredient validation exercise in 2012.
Industry News | Monday, February 06
Lawmakers in the commonwealth of Virginia are debating the implications of breast density notification legislation.
Industry News | Monday, February 06
Revised criteria for the diagnosis of mild cognitive impairment (MCI) could compromise the diagnosis of Alzheimer disease (AD) dementia, according to an analysis published online Feb. 6 in Archives of Neurology.
Awards | Friday, February 03
The Massachusetts Life Sciences Center has awarded Boston’s Dana-Farber Cancer Institute a $10 million grant to support the expansion of its cancer imaging research program.
Clinical Studies | Friday, February 03
The radiopharmaceutical, I-131-MIP-1466, which is designed to deliver a therapeutic dose of radiation to metastatic prostate cancer, will enter a clinical trial to evaluate its efficacy and benefits for patients.
Government News | Wednesday, February 01
The Utah State Senate Health and Human Services Committee on Jan. 31 approved legislation encouraging facilities to notify women of their breast density status. The legislation will be sent to the state Senate for consideration.
Financial News | Monday, January 30
Philips Healthcare has reported a single-digit increase in sales for the fourth quarter of 2011 over the comparable 2010 fourth quarter, and the 2011 fiscal year over 2010.
Clinical Studies | Monday, January 30
With the exception of liver metastases, whole-body imaging of estrogen receptor (ER) expression with 18F-FES, an ER-specific PET tracer, can be a valuable additional diagnostic tool when standard work-up is inconclusive, particularly in breast cancer patients, according to a study published in the February issue of the Journal of Nuclear Medicine.
Clinical Studies | Monday, January 30
The malignancy rate for MR-detected breast masses less than or equal to 5 mm has been shown to be greater than 20 percent, indicating that these small masses should be viewed with a high degree of suspicion when seen in staging breast MRI exams, according to a study published in the January issue of Academic Radiology.
Regulatory News | Monday, January 30
The FDA’s Center for Devices and Radiological Health (CDRH) has released its ombudsman report for 2011, the first year the office’s electronic tracking system has been used to facilitate record-keeping and trending.
Conference News | Monday, January 30
Capital Health, a hospital network based in New Jersey, has inked a contract with GE Healthcare to install GE's Discovery NM 750b at Capital Health Medical Center - Hopewell in Pennington, N.J.
Partnerships & Alliances | Monday, January 30
Karolinska Institutet in Stockholm and AstraZeneca have formed a three-year collaborative research agreement that will apply molecular imaging technologies to generate new diagnostic imaging tools.
Industry News | Sunday, January 29
The Texas Department of State Health Services-Radiation Control Program has granted Positron's wholly owned subsidiary, Manhattan Isotope Technology, approval of its radioactive materials license amendment.
Clinical Studies | Sunday, January 29
Inflammation, as assessed by 18F-FDG-PET uptake and histology, is increased in plaques containing high-risk morphological (HRM) features and rises with increasing number of HRM, according to a study in the January issue of
Circulation: Cardiovascular Imaging. Study authors suggested that data support the concept that inflammation accumulates relative to the burden of morphological abnormalities.
Clinical Studies | Friday, January 27
A new magnetic resonance spectroscopy (MRS) technique may offer a method to detect and track a protein associated with a genetic mutation in brain tumor cancer cells. The method could inform diagnosis of glioma and provide prognostic information, according to a study published online Jan. 26 in Nature Medicine.
Industry News | Friday, January 27
Shine Medical Technologies, a developer of medical isotopes and cancer treatment elements, intends to build a new manufacturing plant in Janesville, Wis. Plant completion is planned for 2015, with more than 100 permanent employees and potential for further employment growth.
Industry News | Thursday, January 26
The diagnostic imaging market will be marked by an expansion of hybrid modality technology, the growth of imaging in emerging markets and negative growth due to reimbursement cuts in the U.S., according to a report by GBI Research, a business information company, distributed by Industry Review.
Industry News | Thursday, January 26
The Florida State Senate has refused to consider HB 1329, which would have required imaging centers, along with other healthcare providers, to publish and post a schedule of charges for services provided to patients paying out of pocket, effective Jan. 25.
Contracts & Installations | Thursday, January 26
Naviscan PET scanners performing positron emission mammography (PEM) have been installed in two European centers: Radiologie und Nuklearmedizin in Ludwigshafen, Germany, and Medica in Istanbul, Turkey.
Mergers & Acquisitions | Wednesday, January 25
Milwaukee-based Herzing University has acquired the Medical Technology Management Institute, which provides continuing education for radiologic technologists and diagnostic medical physicists.
Financial News | Monday, January 23
Venture investments held strong and steady across healthcare in 2011, with medical devices finishing a close second to biopharmaceuticals in dollars invested and healthcare IT seeing a substantial increase over the previous year.
Clinical Studies | Monday, January 23
Often healthcare services in the U.S. are overutilized, which can lead to high healthcare spending. Expanding guidelines and establishing appropriate use criteria for more healthcare services could help eliminate this overuse and in turn reduce high healthcare spending, according to an editorial published in the Jan. 24 issue of the
Archives of Internal Medicine.
Financial News | Monday, January 23
GE Healthcare has reported a 1 percent increase in fourth quarter revenues to $5.16 billion, and a slight drop—5 percent—in quarter profits to $953 million. However, the yearly revenue in 2011 rose 7 percent in 2011 over 2010—$18.08 billion versus $16.9 billion. Likewise, the healthcare unit’s yearly profits rose 2 percent from $2.74 billion in 2010 to $2.8 billion in 2011.
Clinical Studies | Sunday, January 22
18F-flutemetamol PET imaging demonstrates strong concordance with histopathology irrespective of timing and sequence of exams in prospective and retrospective settings, and shows promise as a valuable tool to study and possibly facilitate diagnosis of Alzheimer’s disease, both in patients with suspected normal pressure hydrocephalus, and among the wider population, according to a pooled analysis of four studies presented at the 2012 Human Amyloid Imaging (HAI) conference in Miami, Fla.
Government News | Friday, January 20
The Dutch Ministry of Economic Affairs, Agriculture and Innovation has announced that the government's cabinet views the realization of a new PALLAS nuclear reactor "postively," which is an "important condition for further progress on the PALLAS project," according to a statement from the Nuclear Research & Consultancy Group.
Industry News | Wednesday, January 18
The global PACS market, valued at $2.8 billion in 2010, is expected to grow at a compound annual growth rate (CAGR) of 10 percent to reach $5.4 billion by 2017, according to a MarketResearch.com report titled “Picture Archiving and Communication Systems (PACS) – Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017.”
Mergers & Acquisitions | Tuesday, January 17
Positron has acquired all of the assets and business operations and retained all employees of Manhattan Isotope Technology (MIT). In exchange, MIT will receive cash advances, assumption of certain indebtedness and earn-out consideration of $3.5 million, based on 20 percent of the net income from sales relating to radioisotope and radiopharmaceutical operations of MIT.
Industry News | Tuesday, January 17
Bioscan, a developer of preclinical imaging systems, has established a subsidiary in Dijon, France, Bioscan Molecular Imaging France.
Clinical Studies | Monday, January 16
An interim 18F-FDG PET/CT exam after two cycles of neoadjuvant chemotherapy was predictive of pathologic response and disease-free survival in patients with triple-negative breast cancer, an aggressive subtype of breast cancer, according to a prospective study published online Jan. 12 in the Journal of Nuclear Medicine.
Industry News | Monday, January 16
An internal audit published in late 2010 showed that University of Missouri Health Care was providing unrequested radiology services, according to the Columbia Tribune.
Clinical Studies | Monday, January 16
The team at Johns Hopkins In-Vivo Cellular and Molecular Imaging Center in Baltimore is using novel imaging tools to discover new early detection methods for cancers existing in cells, and study its prevention and elimination before spreading to other organs and tissues.
Government News | Monday, January 16
The Living Lab Structural Biology Center was formed through a cooperative research and development agreement between the National Institutes of Health (NIH), in Bethesda, Md., and FEI, in Hillsboro, Ore., a scientific instruments company, to help accelerate medical discoveries relating to global health challenges, such as cancer and HIV/AIDS. The lab will utilize near-atomic resolution microscopy and other structural biology technologies.
Contracts & Installations | Thursday, January 12
Two healthcare organizations in Grenoble, France, are using LabLogic’s Laura radio-chromatography system and instrumentation.
Government News | Wednesday, January 11
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has released biomarker data from studies intended to improve the ability to diagnose and measure the progression of Alzheimer’s disease.
Industry News | Tuesday, January 10
As the healthcare system abandons fee-for-service reimbursement models for the potential savings of value-based reimbursement models, IT services firm CSC suggested that incentives for patients and providers need to more closely resemble each other for the transition to work.
